You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨石藥(1093.HK)升4.63%創16個月新高 三季報超預期多大行唱好
格隆匯 11-19 10:49
格隆匯11月19日丨石藥集團(1093.HK)今日強勢拉昇,盤中一度升近6%創下16個月新高。現漲4.63%領漲恆指成份股,報21.5港元,暫成交3.98億港元,最新總市值1340.8億港元。石藥集團昨日公佈,前三季純利升24%至28.11億元,創新藥收入達95.25億元。期內,抗腫瘤產品組合的銷售增長達到170.7%,成為集團的新興增長動力,亦使得整體收入構成更加均衡。國金證券點評稱,業績符合預期,恩必普及抗腫瘤新藥雙驅動。中金公司表示,創新藥業務繼續驅動高增長,研發投入加大。維持跑贏行業評級和目標價24港元。瑞信則升石藥目標價至24.91港元,評級“跑贏大市”。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account